Foot And Mouth Disease (FMD) Vaccines Market By Vaccine Type (Conventional Vaccines, Emergency Vaccines), By Animal Type (Cattle, Sheep & Goat, Swine, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global foot and mouth disease (FMD) vaccines market to reach US$ 2,935.1 Mn in 2026 and projected to exhibit a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2018 to 2026. FMD is highly contagious viral disease and sometimes fatal affecting cloven hoofed animals that includes domestic and wild bovids.

Equine Healthcare Market By Product Type (Drug Type, Vaccine Type,Supplements and Additives), By Disease Type (West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus, Equine Influenza, Equine Herpes Virus)- Growth, Future Prospects & Competitive Analysis, 2018 - 2026

$ 4325

The global equine healthcare market held US$ 626.2 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 4.0% during the forecast period from 2018 to 2026. Growing trend of horse breeding and horse riding for leisure purpose is the major growth factor of the equine healthcare market. Other factors such as growing incidence of equine infections and development of novel animal safety and health programs will continue to assist the growth of the market.

Electronic Health Records (EHR) Market By Delivery (On-Premise Server Based, Cloud-Based, Web-Based), By Product (Inpatient HER, Ambulatory HER), By End-User (Hospitals, Clinics And Diagnostic Centers, Ambulatory Care Centers, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global electronic health records (EHR) market held US$ 24,222.5 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026. EHRs are digital form of patient’s medical chart that deliver real-time patient records providing information instantly and securely to authorized user for medical decision making.

Dilated Cardiomyopathy Therapeutics Market By Treatment (Drug Class, Implantable Device) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The dilated cardiomyopathy therapeutics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017 featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.7% during the forecast period from 2018 to 2026.

Diagnostic Testing For STD’s Market By Type (Syphilis Testing, Gonorrhea Testing, Chlamydia Testing, Herpes Simplex Virus Testing, Human Immunodeficiency Virus Testing, Human Papilloma Virus Testing, Others), By Location (Laboratory Testing, Point Of Care Testing) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The diagnostic testing for STD’s market is set to reach US$ 42,329.1 Mn by 2026 from US$ 19,716.9 Mn in 2017 performing steadily at a compounded annual growth rate (CAGR) of 8.9% during the forecast period from 2018 to 2026.

Cutaneous Mastocytosis Treatment Market By Drug Type (Antihistamines, Corticosteroids, Mast Cell Stabilizers, Sympathomimetic Agents, Photochemotherapy), By Pipeline Analysis (Phase III, Phase II) - Growth, Future Prospects and Competitive Analysis, 2018-2026

$ 4325

Cutaneous mastocytosis treatment market accounted for a market value of US$ 186.7 Mn in 2017 and projected to grow at a CAGR of 5.6% during the forecast period from 2018 to 2026. Cutaneous mastocytosis is a rare disease in which uncontrolled production of mast cells leads to skin complications such as lesions, blisters, and rashes with aggravated itching. The key causes of cutaneous mastocytosis are a mutation in KIT gene which leads to overproduction of mast cells and excess accumulation of mast cell in the skin leads to chronic as well as acute reactions.

Chemotherapy Induced Nausea And Vomiting Treatment Market By Drug Class (Serotonin Receptor Antagonist, Neurokinin NK1 Receptor Antagonist, Dopamine Antagonist, Benzodiazepine, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The chemotherapy induced nausea and vomiting treatment market is set to reach US$ 3,626.1 Mn by 2026 from US$ 2,057.4 Mn in 2017 showcasing progressive growth at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2018 to 2026. As per the latest statistics provided by the National Cancer Institute in 2018 approximately 1,735,350 new cancer cases will be reported with an estimation of 609,640 people dying with cancer.

Cervical Cancer Treatment Market By Product (Chemotherapy, Targeted Therapy, Surgical Procedure, Radiation Therapy and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The cervical cancer treatment market will be highlighting excellent growth at a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2018 to 2026. Cervical cancer occurs in women in age group ranging from 14 to 49 years. The human papillomavirus (HPV) is the main causative agent for the occurrence of cervical cancer which is sexually transmitted. Cervical cancer can be prevented by performing early screening test and vaccination using Gardasil against HPV infection.

Cervical Cancer Diagnostic Test Market By Diagnostic Test Type (PAP Tests, HPV Tests, Biopsy, Colposcopy, Cystoscopy) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global cervical cancer diagnostic test market is growing significantly, was valued at US$ 8,779.2 Mn in 2017 and expected to attain US$ XX Mn by 2026. Worldwide growing prevalence of cervical cancer along with growing female population aged between 25 to 60 years are the major factors driving the overall growth of the global cervical cancer diagnostic test market.

Cardiovascular Information Systems Market By Systems Type (CVIS, C-PACS), By Component (Software, Services, Hardware), By Delivery Mode (Web-Based CVIS, Onsite CVIS, Cloud-Based CVIS), By Application (Cardiac And Peripheral Catheterization, Hemodynamics Monitoring, Electrophysiology, Echocardiography, Cardiac CT, Cardiac MRA, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The cardiovascular information systems market stood at US$ 696.7 Mn in 2017 and projected to exhibit a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2018 to 2026. Cardiovascular information system (CVIS) is a kind of electronic health record specifically designed for cardiovascular solutions.

Cancer Diagnostics Market By Test Type (Digital Pathology, Genomic Testing, Cancer Biomarker Tests, Imaging, Endoscopy, Biopsy, Others), By Disease Condition (Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancer, Colorectal Cancer, Ovarian Cancer, Liver Cancer, Other Cancers) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global cancer diagnostics market to reach US$ 115.3 Bn in 2026 growing at compound annual growth rate (CAGR) of 6.1% during the forecast period from 2018 to 2026. The prime factors driving the global cancer diagnostics market is the rising prevalence of cancer worldwide.

Bronchitis Treatment Market By Type Of Drug Class (Antitussives/ Expectorants, Bronchodilators, Beta-Adrenergic Agonist, Systemic Corticosteroids, Inhaled Corticosteroids, Phosphodiesterase-4 Inhibitors, Analgesics, Antibiotics) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026

$ 4325

Bronchitis treatment market accounted for a market value of US$ 3,345.8 Mn in 2017 and projected to grow at a CAGR of 4.9% during the forecast period from 2018 to 2026. Bronchitis treatment market is growing gradually throughout the forecast period due to strong product pipeline equipped with target-specific drugs, and rising prevalence & awareness related to the treatment & diagnosis of bronchitis.

Blood-Brain Barrier Market By Disease Type (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer), By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing The Permeability Of BBB, Passive Diffusion, Other) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The global blood-brain barrier market projected to reach US$ 5,704.2 Mn by 2026 from US$ 696.4 Mn in 2017, growing at a CAGR of 25.0% during the forecast period from 2018 to 2026. The blood-brain barrier (BBB) prevents free flow of elements from circulatory system to the cerebrospinal fluid (CSF) or brain with specific exchange of elements regulated by blood-brain barrier and blood-CSF barrier.

Blockchain Technology in Healthcare Market By Application (Data Exchange and Interoperability, Supply Chain Management, Claims Adjudication and Billing Management, Others), By End-user (Pharmaceutical Companies, Healthcare Payers, Healthcare Providers, Research and Academia, Others, Gels) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026

$ 4325

Blockchain technology in healthcare is being acknowledged to have revolutionary impact on the healthcare system enabling its complete transformation through digitization. As digitization of all industries has continued to expand over the decades, the blockchain technology entered the market in 2016, despite its introduction in 2008. Blockchain technology has touched several industries deployed with vast information, technologies and artificial intelligence. The concept of blockchain represents a network of blocks that continuously grow and change, that adapt to specific industry. Blockchain is based on distributed ledgers containing facts and information.

Transdermal Skin Patches Market By Product (Matrix, Drug In Adhesive, Reservoir, Multilaminate), By Application (Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Motion Sickness, Neurological Disorder, Cardiovascular Disorder) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

$ 4325

Transdermal skin patches is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medical through the skin and in the bloodstream. The patch contains the medication prescribed to the patient and is designed in such a way that the medication permeates the skin in a controlled fashion thus attaining more steady levels of the drug in the body.

Orthopedic Oncology Treatment Market By Type Of Procedure (Soft Tissue Excisions/Resections, Limb Salvage Surgery, Amputation, Adjuvant Chemotherapy, Reconstructive Surgery) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

$ 4325

Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of musculoskeletal system which includes trauma, spine, hand and upper extremity, total joints and even pediatric orthopedics.

Clinical Nutrition Market By Type (Pediatric Nutrition, Enteral Nutrition, Parenteral Nutrition), Medical Condition (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery & Others) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

$ 4325

Escalating geriatric population, increasing birth rate, growth in number of premature births and intensified prevalence of malnutrition and chronic diseases are the prime contributors to the growing demand for clinical nutrition. Malnutrition is a grave issue faced affecting millions globally and clinical nutrition is the most effective way to treat malnutrition.

Cholera Vaccines Market By Product Type (Dukoral, Shanchol, Vaxchora, Other Vaccines) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

$ 4325

Global cholera vaccines market is anticipated to grow significantly during forecast period due to rising government initiatives in immunization program and growing incidence of cholera particularly in developing countries in Asia and Africa would drive the growth of cholera vaccines market globally.

Vitamin D Therapy Market By Route of Administration (Oral and Parenteral), By Application (Osteoporosis, Rickets, Autoimmune Disorder and Skin Disease) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

$ 4325

The vitamin D therapy market is set to reach US$ 4,721.9 Mn by 2027 from US$ 1,919.4 Mn in 2018 showcasing spectacular growth at a compounded annual growth rate (CAGR) of 10.6% during the forecast period from 2019 to 2027. As per the research findings of International Osteoporosis Foundation (IOF), one in three women and one in five men above the age of 50 years is prone to suffer with fracture during their lifetime. Malnourishment, increasing consumption of alcohol & tobacco and hormonal imbalance are causing bone and skin disorders associated with vitamin D deficiency.

Thyroid Function Test Market By Test (TSH Test, T4 Test, T3 Test, Others), By End User (Hospital And Clinics, Diagnostic Laboratory, Others) - Growth, Future Prospects And Competitive Landscape, 2019 – 2027

$ 4325

The thyroid function test market is set to reach US$ 2,203.7 Mn by 2027 from US$ 1,317.8 Mn in 2018 projecting impressive growth at a compounded annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026. The major risk factors associated with thyroid disorders are intake of iodine replete diet, hormonal imbalance, sedentary lifestyle and increasing consumption of alcohol and tobacco. Increasing public health awareness and technological advancement in diagnostic kits together drive the thyroid function tests market growth.